Bionomics Limited (NASDAQ:BNOX – Get Rating) was the recipient of a large growth in short interest during the month of December. As of December 30th, there was short interest totalling 1,000 shares, a growth of 150.0% from the December 15th total of 400 shares. Based on an average trading volume of 6,300 shares, the days-to-cover ratio is currently 0.2 days.
Bionomics Stock Performance
Shares of BNOX stock traded down $0.22 during trading hours on Wednesday, reaching $4.13. 95 shares of the company's stock were exchanged, compared to its average volume of 3,657. The stock's 50 day moving average is $6.07 and its 200-day moving average is $7.02. Bionomics has a fifty-two week low of $3.51 and a fifty-two week high of $12.99.
Get Bionomics alerts:Analysts Set New Price Targets
BNOX has been the topic of a number of research reports. HC Wainwright lowered shares of Bionomics from a "buy" rating to a "neutral" rating in a research report on Monday, December 19th. Loop Capital assumed coverage on shares of Bionomics in a research note on Tuesday, November 1st. They issued a "buy" rating and a $23.00 price objective for the company. Finally, Evercore ISI restated an "in-line" rating and set a $6.00 price objective (down from $17.00) on shares of Bionomics in a research note on Tuesday, December 20th.
About Bionomics
(Get Rating)Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder.
See Also
- Get a free copy of the StockNews.com research report on Bionomics (BNOX)
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.